Tuberculosis (TB) is a potentially serious infectious disease caused by the bacterium Mycobacterium tuberculosis. The bacteria typically affect the lungs, but they can also affect other parts of the body such as the kidney, spine, and brain. Not everyone infected with TB bacteria becomes sick, which leads to the distinctions between latent TB infection (LTBI) and TB disease.

**Historical Context and Discovery:**
Tuberculosis has plagued human populations for millennia, with evidence of the disease found in ancient mummies. It was historically referred to as "consumption" due to the way it would consume from within those who suffered from it. The causative agent, Mycobacterium tuberculosis, was discovered in 1882 by German physician Robert Koch, who received the Nobel Prize in Physiology or Medicine for this discovery in 1905. Successful vaccine development (BCG) occurred in the early 20th century, and the advent of effective antibiotic treatments, beginning with streptomycin in the 1940s, drastically reduced TB deaths and prevalence in the developed world.

**Global Prevalence:**
As of my knowledge cutoff in April 2023, TB remains one of the top 10 causes of death worldwide and is the leading cause from a single infectious agent, ranking above HIV/AIDS. The World Health Organization (WHO) estimated that in 2021, approximately 10.6 million people fell ill with TB worldwide, with 1.6 million deaths, including among 214,000 people with HIV. Multidrug-resistant TB (MDR-TB) remains a public health crisis and a health security threat.

**Transmission Routes:**
TB is spread from person to person through the air. When people with lung TB cough, sneeze, or spit, they propel TB bacteria into the air. A person needs to inhale only a few of these germs to become infected. Not everyone infected with TB bacteria becomes ill, and as a result, two TB-related conditions exist: latent TB infection and TB disease.

**Affected Populations:**
All age groups and demographics can be affected by TB, but the disease is most often found in adults, particularly those who are immunocompromised. The highest prevalence of TB is in developing countries in Sub-Saharan Africa, Asia, and Latin America, due to factors such as crowded living conditions, poor nutrition, and lack of access to medical care.

**Key Statistics:**
Eight countries account for two-thirds of the total, with India leading the count, followed by China, Indonesia, the Philippines, Pakistan, Nigeria, Bangladesh, and South Africa. MDR-TB is a form of TB infection caused by bacteria that are resistant to treatment with at least isoniazid and rifampin, the two most potent TB drugs.

**Major Risk Factors for Transmission:**
- Close contact with an infectious person
- Immune system weakness, for instance due to HIV/AIDS, diabetes, or certain medications
- Poor living conditions, including overcrowding and inadequate ventilation
- Substance abuse
- Healthcare work, with a higher risk due to frequent contact with people with TB

**Impact on Different Regions and Populations:**
TB impacts various regions differently, with the highest burdens often in places with weak healthcare systems or in populations with high rates of comorbid conditions. For example, countries with high HIV prevalence often face co-epidemics of TB and HIV. These co-infections complicate treatment and worsen outcomes, as the immune suppression caused by HIV increases the risk of progressing from latent to active TB disease.

In higher-income countries, TB tends to affect marginalized groups such as the homeless, those in poverty, prisoners, and immigrants from high TB burden countries. Rates of TB in these populations remain disproportionately high despite low overall country prevalence.

**Variations in Prevalence Rates and Affected Demographics:**
TB prevalence is generally higher in men than in women and is particularly prevalent among young adults. Economically disadvantaged and marginalized communities are disproportionately affected due to the risk factors mentioned earlier. Children can also be affected by TB, with a significant number of pediatric cases and related deaths each year.

The demographic and regional impacts of TB have remained somewhat consistent over time, with the most substantial incidence and prevalence rates occurring in Asia and Africa. However, international efforts, including the Stop TB Partnership and other initiatives supported by the WHO, aim to reduce both the incidence of TB and the mortality associated with it.

**Control and Prevention Efforts:**
Control of TB involves a mix of public health initiatives including vaccination, which in most countries is with the Bacille Calmette-Guerin (BCG) vaccine, diagnostics, antibiotic treatments, and surveillance strategies to monitor and treat affected populations. Directly observed treatment, short-course (DOTS) strategy, has been a cornerstone in the management of TB, ensuring that patients complete their full course of medication.

Prevention and control require a multifaceted approach, including improved living conditions, reduction of other risk factors like smoking and HIV transmission, better diagnostics, more effective vaccines, and the adherence to treatment protocols.